DEMADN: THE FUTURE OF PERSONALIZED MEDICINE

DEMADN, or Dynamic Biological Assessment Platform, represents a significant shift in the landscape of patient care. This novel technology aims to enhance personalized therapy by interpreting vast volumes of patient data – including genetic information and biomolecular data – to anticipate disease